There are about roughly 442 million individuals who are fighting a constant battle within themselves against Diabetes. It is a chronic and metabolic disease characterized by elevated blood sugar levels which leads to serious internal body damage such as heart disease, kidney failure, eyes, nerves, and blood vessel damage. These are the very reason why it is also considered Rust for the Human body.
Blood pressure is a major factor for diabetic patients. People with diabetes have to undergo certain lifestyle changes and these changes can vary depending on the severity of their condition. From dietary changes, and exercise, with the goal of keeping both short-term and long-term blood glucose levels within acceptable bounds, individuals have to exercise regularly. In addition, given the associated higher risks of cardiovascular disease, lifestyle modifications are recommended to control blood pressure.
Frontiers in Clinical Drug Research – Diabetes and Obesity is an eBook series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of two metabolic diseases – diabetes and obesity. The scope of the eBook series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology, and biochemistry of natural and synthetic drugs affecting endocrine and metabolic processes linked with diabetes and obesity. Reviews in this series also include research on specific receptor targets and pre-clinical / clinical findings on novel pharmaceutical agents. The fourth volume of this series features 7 chapters:
- -Pharmacologic Obesity Treatment
- -Interplay Between Bile Acid and GLP-1 Receptor Agonist Signaling Informs the Design of Drugs to Combat Obesity and its Metabolic Complications
- -Sodium-Glucose Co-Transporters Inhibitors for Type 2 Diabetes Mellitus
- -The Effects of Traditional Chinese Medicine on Inflammatory Cytokines in Diabetic Nephropathy
- -Through the Perspective of Histology – The Alzheimer’s Disease Promotion by Obesity and Glucose Metabolism: Type 3 Diabetes
- -Pharmacological Mechanism of PPARγ Ratio in Diabetes and Obesity
- -Hydrogen Sulfide and Carbohydrate Metabolism